| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nasopharyngeal Neoplasms | 40 | 2026 | 51 | 11.560 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 19 | 2026 | 465 | 3.460 |
Why?
|
| Chemoradiotherapy | 20 | 2026 | 75 | 3.210 |
Why?
|
| Ovarian Neoplasms | 6 | 2026 | 170 | 3.200 |
Why?
|
| Neoplasm Recurrence, Local | 11 | 2026 | 377 | 3.100 |
Why?
|
| Cisplatin | 18 | 2026 | 145 | 2.680 |
Why?
|
| Alzheimer Disease | 14 | 2025 | 766 | 2.380 |
Why?
|
| Induction Chemotherapy | 11 | 2026 | 44 | 1.850 |
Why?
|
| Cachexia | 2 | 2026 | 13 | 1.770 |
Why?
|
| Muscular Atrophy | 2 | 2026 | 30 | 1.730 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2025 | 253 | 1.670 |
Why?
|
| Ion Channels | 6 | 2023 | 92 | 1.660 |
Why?
|
| Sarcopenia | 2 | 2024 | 28 | 1.620 |
Why?
|
| Animals | 79 | 2026 | 21394 | 1.600 |
Why?
|
| Transient Receptor Potential Channels | 4 | 2022 | 10 | 1.590 |
Why?
|
| Caenorhabditis elegans | 4 | 2025 | 707 | 1.570 |
Why?
|
| Nociception | 3 | 2022 | 8 | 1.530 |
Why?
|
| Humans | 132 | 2026 | 65498 | 1.500 |
Why?
|
| Peptides | 9 | 2026 | 590 | 1.490 |
Why?
|
| Endometrial Neoplasms | 2 | 2023 | 77 | 1.490 |
Why?
|
| Capecitabine | 5 | 2025 | 14 | 1.480 |
Why?
|
| Drosophila Proteins | 12 | 2023 | 758 | 1.470 |
Why?
|
| Pyridines | 2 | 2024 | 120 | 1.420 |
Why?
|
| Gestational Trophoblastic Disease | 4 | 2023 | 4 | 1.280 |
Why?
|
| Prognosis | 20 | 2026 | 1789 | 1.280 |
Why?
|
| Immunotherapy | 4 | 2025 | 273 | 1.240 |
Why?
|
| Female | 74 | 2026 | 34216 | 1.230 |
Why?
|
| Caenorhabditis elegans Proteins | 3 | 2025 | 448 | 1.220 |
Why?
|
| Drosophila | 7 | 2023 | 479 | 1.200 |
Why?
|
| Drosophila melanogaster | 9 | 2020 | 560 | 1.200 |
Why?
|
| Burns | 3 | 2024 | 45 | 1.190 |
Why?
|
| Biosensing Techniques | 5 | 2025 | 126 | 1.170 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2026 | 27 | 1.090 |
Why?
|
| Gene Expression Regulation, Plant | 3 | 2025 | 37 | 1.090 |
Why?
|
| Middle Aged | 47 | 2026 | 18393 | 1.080 |
Why?
|
| Nociceptors | 4 | 2022 | 13 | 1.060 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2025 | 105 | 1.060 |
Why?
|
| Fluorouracil | 9 | 2026 | 68 | 1.060 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2026 | 350 | 1.050 |
Why?
|
| Carcinoma | 12 | 2018 | 130 | 1.040 |
Why?
|
| Paclitaxel | 4 | 2025 | 102 | 1.030 |
Why?
|
| Amyloid beta-Peptides | 8 | 2025 | 321 | 1.020 |
Why?
|
| Deoxycytidine | 2 | 2024 | 45 | 1.010 |
Why?
|
| China | 9 | 2026 | 177 | 1.000 |
Why?
|
| Brassica napus | 3 | 2024 | 3 | 1.000 |
Why?
|
| Male | 68 | 2026 | 31208 | 0.990 |
Why?
|
| Mice | 39 | 2026 | 11145 | 0.970 |
Why?
|
| Aged | 37 | 2026 | 15062 | 0.960 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2026 | 27 | 0.950 |
Why?
|
| Albumins | 2 | 2024 | 43 | 0.950 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 183 | 0.950 |
Why?
|
| Indazoles | 1 | 2026 | 19 | 0.940 |
Why?
|
| Neoplasms | 4 | 2025 | 1372 | 0.940 |
Why?
|
| Adult | 42 | 2026 | 17467 | 0.940 |
Why?
|
| Transcription Factors | 2 | 2025 | 1557 | 0.940 |
Why?
|
| Pore Forming Cytotoxic Proteins | 4 | 2025 | 34 | 0.940 |
Why?
|
| Piperidines | 1 | 2026 | 73 | 0.910 |
Why?
|
| Axons | 3 | 2023 | 124 | 0.910 |
Why?
|
| Biomarkers | 6 | 2024 | 1484 | 0.890 |
Why?
|
| Droughts | 1 | 2025 | 2 | 0.890 |
Why?
|
| Theileria | 1 | 2024 | 1 | 0.870 |
Why?
|
| Babesia | 1 | 2024 | 2 | 0.870 |
Why?
|
| Anaplasma | 1 | 2024 | 2 | 0.870 |
Why?
|
| Fibrinolytic Agents | 1 | 2026 | 183 | 0.870 |
Why?
|
| Circulating Tumor DNA | 1 | 2024 | 11 | 0.870 |
Why?
|
| Neoplasm Metastasis | 11 | 2026 | 223 | 0.870 |
Why?
|
| Zea mays | 1 | 2025 | 32 | 0.870 |
Why?
|
| Rickettsia | 1 | 2024 | 3 | 0.870 |
Why?
|
| Thrombolytic Therapy | 1 | 2026 | 204 | 0.870 |
Why?
|
| Neoplasm, Residual | 1 | 2024 | 52 | 0.850 |
Why?
|
| Ticks | 1 | 2024 | 35 | 0.850 |
Why?
|
| Signal Transduction | 18 | 2026 | 3156 | 0.840 |
Why?
|
| Plant Proteins | 1 | 2025 | 93 | 0.820 |
Why?
|
| Myostatin | 1 | 2024 | 20 | 0.820 |
Why?
|
| Atherosclerosis | 2 | 2022 | 162 | 0.790 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 64 | 0.790 |
Why?
|
| Ultraviolet Rays | 5 | 2023 | 153 | 0.780 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2024 | 268 | 0.770 |
Why?
|
| Transforming Growth Factor beta | 1 | 2024 | 181 | 0.770 |
Why?
|
| Adult Stem Cells | 1 | 2023 | 30 | 0.770 |
Why?
|
| Chlorobenzenes | 1 | 2023 | 30 | 0.760 |
Why?
|
| Disease Models, Animal | 15 | 2026 | 2307 | 0.760 |
Why?
|
| Cognitive Dysfunction | 3 | 2024 | 350 | 0.750 |
Why?
|
| Adenosine | 1 | 2023 | 78 | 0.740 |
Why?
|
| Retrospective Studies | 23 | 2025 | 6939 | 0.740 |
Why?
|
| Histones | 3 | 2024 | 497 | 0.730 |
Why?
|
| Mitochondria | 8 | 2026 | 410 | 0.720 |
Why?
|
| Antineoplastic Agents | 6 | 2025 | 643 | 0.720 |
Why?
|
| Muscle, Skeletal | 5 | 2026 | 787 | 0.720 |
Why?
|
| Granulosa Cell Tumor | 1 | 2021 | 6 | 0.710 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 34 | 0.710 |
Why?
|
| Neoplasm Staging | 9 | 2025 | 552 | 0.700 |
Why?
|
| Latent Tuberculosis | 1 | 2022 | 24 | 0.700 |
Why?
|
| Capsule Opacification | 1 | 2021 | 1 | 0.700 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2021 | 4 | 0.690 |
Why?
|
| Lenses, Intraocular | 1 | 2021 | 7 | 0.690 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2025 | 263 | 0.690 |
Why?
|
| Parabiosis | 1 | 2021 | 3 | 0.690 |
Why?
|
| Endophthalmitis | 1 | 2021 | 16 | 0.690 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2021 | 6 | 0.680 |
Why?
|
| Apoptosis | 8 | 2026 | 1098 | 0.680 |
Why?
|
| Fundus Oculi | 1 | 2021 | 26 | 0.680 |
Why?
|
| Inflammation | 5 | 2026 | 1194 | 0.670 |
Why?
|
| Electrochemical Techniques | 4 | 2025 | 21 | 0.670 |
Why?
|
| Photography | 1 | 2021 | 43 | 0.670 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2021 | 11 | 0.660 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2022 | 123 | 0.640 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 100 | 0.620 |
Why?
|
| Thioacetamide | 1 | 2020 | 5 | 0.620 |
Why?
|
| beta-Lactamases | 1 | 2020 | 18 | 0.620 |
Why?
|
| Seeds | 1 | 2020 | 29 | 0.610 |
Why?
|
| Genes, Recessive | 1 | 2020 | 51 | 0.610 |
Why?
|
| Neurons | 7 | 2025 | 934 | 0.610 |
Why?
|
| Endovascular Procedures | 1 | 2026 | 631 | 0.600 |
Why?
|
| Light | 3 | 2025 | 194 | 0.600 |
Why?
|
| Triazoles | 1 | 2020 | 63 | 0.600 |
Why?
|
| Alternative Splicing | 2 | 2019 | 138 | 0.590 |
Why?
|
| Methylation | 3 | 2017 | 130 | 0.590 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2025 | 733 | 0.570 |
Why?
|
| Propensity Score | 6 | 2026 | 192 | 0.560 |
Why?
|
| Epithelial Cells | 7 | 2024 | 413 | 0.550 |
Why?
|
| Tuberculosis | 1 | 2022 | 312 | 0.550 |
Why?
|
| Biomedical Research | 1 | 2021 | 263 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 12 | 2026 | 3489 | 0.530 |
Why?
|
| MicroRNAs | 3 | 2021 | 714 | 0.530 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 213 | 0.530 |
Why?
|
| RNA | 2 | 2021 | 426 | 0.520 |
Why?
|
| Brain | 9 | 2025 | 1611 | 0.520 |
Why?
|
| Lung Neoplasms | 5 | 2024 | 708 | 0.510 |
Why?
|
| Transcriptome | 4 | 2026 | 399 | 0.510 |
Why?
|
| Longevity | 3 | 2023 | 117 | 0.510 |
Why?
|
| Amphibian Proteins | 3 | 2023 | 9 | 0.500 |
Why?
|
| Mammals | 3 | 2023 | 222 | 0.500 |
Why?
|
| Phenotype | 6 | 2024 | 1233 | 0.490 |
Why?
|
| DNA Damage | 2 | 2023 | 298 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 630 | 0.470 |
Why?
|
| Mechanotransduction, Cellular | 4 | 2022 | 28 | 0.450 |
Why?
|
| Repressor Proteins | 3 | 2020 | 351 | 0.450 |
Why?
|
| Reactive Oxygen Species | 8 | 2025 | 237 | 0.440 |
Why?
|
| Airway Remodeling | 3 | 2024 | 22 | 0.440 |
Why?
|
| Nomograms | 4 | 2025 | 20 | 0.430 |
Why?
|
| Asthma | 3 | 2024 | 485 | 0.420 |
Why?
|
| Organoplatinum Compounds | 3 | 2026 | 23 | 0.420 |
Why?
|
| DNA | 6 | 2025 | 852 | 0.410 |
Why?
|
| Photoreceptor Cells, Invertebrate | 2 | 2011 | 38 | 0.410 |
Why?
|
| Anura | 6 | 2023 | 34 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 4 | 2026 | 806 | 0.410 |
Why?
|
| Methotrexate | 2 | 2024 | 80 | 0.400 |
Why?
|
| Peptide Fragments | 1 | 2015 | 417 | 0.390 |
Why?
|
| Cattle | 3 | 2024 | 320 | 0.390 |
Why?
|
| Optical Imaging | 3 | 2019 | 77 | 0.390 |
Why?
|
| Treatment Outcome | 13 | 2026 | 5811 | 0.390 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2020 | 105 | 0.390 |
Why?
|
| Promoter Regions, Genetic | 4 | 2025 | 687 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2025 | 2247 | 0.390 |
Why?
|
| Fatty Acids | 2 | 2026 | 199 | 0.380 |
Why?
|
| Nerve Regeneration | 3 | 2023 | 38 | 0.380 |
Why?
|
| Prospective Studies | 6 | 2026 | 3326 | 0.370 |
Why?
|
| Young Adult | 15 | 2025 | 4839 | 0.370 |
Why?
|
| Integrin beta4 | 3 | 2023 | 35 | 0.360 |
Why?
|
| Gene Expression Profiling | 4 | 2026 | 796 | 0.360 |
Why?
|
| Mice, Transgenic | 9 | 2025 | 1290 | 0.360 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2025 | 92 | 0.360 |
Why?
|
| Receptors, Immunologic | 2 | 2023 | 179 | 0.350 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 279 | 0.350 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 526 | 0.350 |
Why?
|
| DNA Methylation | 3 | 2022 | 306 | 0.340 |
Why?
|
| Gold | 4 | 2021 | 235 | 0.340 |
Why?
|
| Presenilin-1 | 6 | 2025 | 66 | 0.340 |
Why?
|
| Bone Neoplasms | 2 | 2024 | 123 | 0.330 |
Why?
|
| Lipid Metabolism | 2 | 2025 | 225 | 0.330 |
Why?
|
| Blood Proteins | 2 | 2023 | 84 | 0.320 |
Why?
|
| Protein Isoforms | 4 | 2019 | 201 | 0.310 |
Why?
|
| Herpesvirus 4, Human | 4 | 2021 | 199 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 152 | 0.310 |
Why?
|
| Bacteria | 2 | 2026 | 336 | 0.310 |
Why?
|
| Amyloid beta-Protein Precursor | 5 | 2025 | 87 | 0.300 |
Why?
|
| TRPA1 Cation Channel | 3 | 2022 | 5 | 0.300 |
Why?
|
| Maintenance Chemotherapy | 2 | 2026 | 17 | 0.300 |
Why?
|
| Pregnancy | 5 | 2023 | 2392 | 0.290 |
Why?
|
| Water Purification | 2 | 2026 | 9 | 0.290 |
Why?
|
| Pyroglyphidae | 4 | 2024 | 7 | 0.290 |
Why?
|
| Aging | 2 | 2026 | 774 | 0.290 |
Why?
|
| Cholecystolithiasis | 1 | 2008 | 2 | 0.280 |
Why?
|
| Poly A | 2 | 2019 | 29 | 0.280 |
Why?
|
| Choledocholithiasis | 1 | 2008 | 7 | 0.280 |
Why?
|
| Bile | 1 | 2008 | 19 | 0.280 |
Why?
|
| Multicenter Studies as Topic | 2 | 2026 | 160 | 0.280 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2008 | 12 | 0.280 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2725 | 0.280 |
Why?
|
| Cell Line | 10 | 2020 | 2024 | 0.280 |
Why?
|
| Vomiting | 3 | 2025 | 139 | 0.280 |
Why?
|
| Autophagy | 5 | 2023 | 238 | 0.270 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2025 | 53 | 0.270 |
Why?
|
| Copper | 2 | 2025 | 57 | 0.270 |
Why?
|
| Silver | 2 | 2025 | 16 | 0.270 |
Why?
|
| Metal Nanoparticles | 2 | 2021 | 191 | 0.270 |
Why?
|
| Terpenes | 3 | 2022 | 28 | 0.260 |
Why?
|
| Phosphorylation | 4 | 2025 | 962 | 0.260 |
Why?
|
| Dioxygenases | 1 | 2007 | 36 | 0.260 |
Why?
|
| Pneumonia | 2 | 2023 | 295 | 0.260 |
Why?
|
| Ozone | 2 | 2026 | 20 | 0.260 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2026 | 159 | 0.260 |
Why?
|
| Thrombocytopenia | 2 | 2026 | 59 | 0.260 |
Why?
|
| Phylogeny | 2 | 2024 | 389 | 0.250 |
Why?
|
| Fibrosis | 2 | 2024 | 172 | 0.250 |
Why?
|
| Lymph Nodes | 2 | 2025 | 237 | 0.250 |
Why?
|
| Retinal Ganglion Cells | 2 | 2025 | 34 | 0.250 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 218 | 0.250 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2019 | 25 | 0.250 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2026 | 97 | 0.250 |
Why?
|
| Equivalence Trials as Topic | 1 | 2026 | 17 | 0.240 |
Why?
|
| Superoxide Dismutase | 2 | 2025 | 223 | 0.240 |
Why?
|
| Cells, Cultured | 7 | 2024 | 2188 | 0.240 |
Why?
|
| Bacterial Toxins | 2 | 2019 | 58 | 0.240 |
Why?
|
| Meat | 2 | 2024 | 38 | 0.240 |
Why?
|
| Polyploidy | 1 | 2026 | 13 | 0.240 |
Why?
|
| Aged, 80 and over | 7 | 2026 | 5650 | 0.240 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2026 | 10 | 0.240 |
Why?
|
| Computational Biology | 2 | 2024 | 368 | 0.240 |
Why?
|
| Glucosides | 1 | 2026 | 15 | 0.240 |
Why?
|
| Administration, Intravenous | 1 | 2026 | 76 | 0.240 |
Why?
|
| Water Microbiology | 1 | 2026 | 16 | 0.240 |
Why?
|
| Antioxidants | 2 | 2025 | 250 | 0.240 |
Why?
|
| 5-Methylcytosine | 1 | 2025 | 24 | 0.230 |
Why?
|
| Stilbenes | 1 | 2026 | 22 | 0.230 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2024 | 44 | 0.230 |
Why?
|
| Metabolome | 1 | 2026 | 36 | 0.230 |
Why?
|
| Rhodopsin | 1 | 2025 | 15 | 0.230 |
Why?
|
| Algorithms | 5 | 2024 | 1050 | 0.230 |
Why?
|
| Bacterial Proteins | 2 | 2023 | 741 | 0.230 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2025 | 25 | 0.230 |
Why?
|
| Microbial Viability | 1 | 2026 | 56 | 0.230 |
Why?
|
| Anthraquinones | 1 | 2025 | 5 | 0.230 |
Why?
|
| Organoids | 1 | 2026 | 41 | 0.230 |
Why?
|
| Lysosomes | 2 | 2019 | 174 | 0.230 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2025 | 9 | 0.230 |
Why?
|
| Adipocytes, Brown | 1 | 2026 | 46 | 0.230 |
Why?
|
| Hematopoiesis | 1 | 2026 | 127 | 0.230 |
Why?
|
| Neuronal Plasticity | 2 | 2021 | 153 | 0.230 |
Why?
|
| Retinal Degeneration | 1 | 2025 | 28 | 0.230 |
Why?
|
| Thyroxine | 1 | 2025 | 55 | 0.230 |
Why?
|
| Immunoconjugates | 1 | 2026 | 95 | 0.230 |
Why?
|
| Hypothyroidism | 1 | 2025 | 43 | 0.230 |
Why?
|
| Ultrasonic Therapy | 1 | 2025 | 9 | 0.230 |
Why?
|
| Myotonia Congenita | 1 | 2025 | 2 | 0.230 |
Why?
|
| Codonopsis | 1 | 2025 | 1 | 0.230 |
Why?
|
| Blepharoptosis | 1 | 2025 | 7 | 0.230 |
Why?
|
| Clinical Protocols | 1 | 2026 | 138 | 0.230 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2025 | 3 | 0.220 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2025 | 33 | 0.220 |
Why?
|
| Area Under Curve | 2 | 2023 | 149 | 0.220 |
Why?
|
| Starvation | 1 | 2025 | 11 | 0.220 |
Why?
|
| Mitochondrial Dynamics | 1 | 2025 | 13 | 0.220 |
Why?
|
| Plants, Genetically Modified | 1 | 2025 | 23 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2026 | 808 | 0.220 |
Why?
|
| Rhodobacter sphaeroides | 1 | 2024 | 8 | 0.220 |
Why?
|
| Genome, Plant | 1 | 2024 | 6 | 0.220 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2024 | 13 | 0.220 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2025 | 46 | 0.220 |
Why?
|
| Multimorbidity | 1 | 2025 | 53 | 0.220 |
Why?
|
| Prostatic Neoplasms | 2 | 2019 | 498 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 586 | 0.220 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2024 | 10 | 0.220 |
Why?
|
| Respiratory System | 2 | 2022 | 46 | 0.220 |
Why?
|
| Cattle Diseases | 1 | 2024 | 11 | 0.220 |
Why?
|
| Tick-Borne Diseases | 1 | 2024 | 8 | 0.220 |
Why?
|
| Case-Control Studies | 4 | 2022 | 1143 | 0.220 |
Why?
|
| Hydrogen | 1 | 2024 | 30 | 0.220 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2024 | 3 | 0.210 |
Why?
|
| Muscle Development | 1 | 2025 | 60 | 0.210 |
Why?
|
| Ferrocyanides | 1 | 2024 | 2 | 0.210 |
Why?
|
| Thallium | 1 | 2024 | 2 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 1 | 2025 | 132 | 0.210 |
Why?
|
| Recovery of Function | 1 | 2026 | 290 | 0.210 |
Why?
|
| Radiotherapy, Intensity-Modulated | 3 | 2020 | 37 | 0.210 |
Why?
|
| Cathepsin K | 1 | 2024 | 8 | 0.210 |
Why?
|
| Cities | 1 | 2024 | 33 | 0.210 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2024 | 13 | 0.210 |
Why?
|
| Monocytes | 3 | 2022 | 361 | 0.210 |
Why?
|
| Honey | 1 | 2024 | 2 | 0.210 |
Why?
|
| Cobalt | 1 | 2024 | 17 | 0.210 |
Why?
|
| Cell Proliferation | 4 | 2023 | 1039 | 0.210 |
Why?
|
| Quantitative Trait Loci | 1 | 2024 | 82 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2025 | 77 | 0.210 |
Why?
|
| Polystyrenes | 1 | 2024 | 35 | 0.210 |
Why?
|
| TRPC Cation Channels | 2 | 2016 | 13 | 0.210 |
Why?
|
| Nanostructures | 3 | 2021 | 187 | 0.210 |
Why?
|
| Air Pollution | 1 | 2024 | 42 | 0.210 |
Why?
|
| Materia Medica | 1 | 2023 | 1 | 0.210 |
Why?
|
| Seasons | 1 | 2024 | 139 | 0.200 |
Why?
|
| Oligosaccharides | 1 | 2024 | 55 | 0.200 |
Why?
|
| Water Pollutants, Chemical | 1 | 2024 | 43 | 0.200 |
Why?
|
| Particulate Matter | 1 | 2024 | 72 | 0.200 |
Why?
|
| Gene Regulatory Networks | 2 | 2026 | 160 | 0.200 |
Why?
|
| Oxidative Stress | 5 | 2025 | 321 | 0.200 |
Why?
|
| Quality of Life | 3 | 2026 | 1263 | 0.200 |
Why?
|
| Disease-Free Survival | 6 | 2025 | 244 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 699 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2025 | 155 | 0.200 |
Why?
|
| Acute Kidney Injury | 1 | 2025 | 142 | 0.200 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 62 | 0.200 |
Why?
|
| Polysaccharides | 1 | 2025 | 154 | 0.200 |
Why?
|
| Prevalence | 2 | 2024 | 1451 | 0.200 |
Why?
|
| Environmental Monitoring | 1 | 2024 | 155 | 0.200 |
Why?
|
| Dialysis Solutions | 1 | 2023 | 7 | 0.200 |
Why?
|
| Single-Cell Analysis | 2 | 2026 | 117 | 0.200 |
Why?
|
| Burkholderiaceae | 1 | 2023 | 1 | 0.200 |
Why?
|
| Iron | 1 | 2024 | 155 | 0.200 |
Why?
|
| Amphibians | 1 | 2023 | 27 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2024 | 100 | 0.190 |
Why?
|
| Operon | 1 | 2023 | 31 | 0.190 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 1568 | 0.190 |
Why?
|
| Cell Movement | 6 | 2019 | 482 | 0.190 |
Why?
|
| Models, Molecular | 2 | 2020 | 1155 | 0.190 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 195 | 0.190 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 790 | 0.190 |
Why?
|
| Hippocampus | 3 | 2025 | 276 | 0.190 |
Why?
|
| DNA Glycosylases | 1 | 2023 | 22 | 0.190 |
Why?
|
| Guanine | 1 | 2023 | 26 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2015 | 226 | 0.190 |
Why?
|
| Hydrogen Peroxide | 3 | 2022 | 83 | 0.190 |
Why?
|
| Molecular Structure | 2 | 2024 | 315 | 0.190 |
Why?
|
| Glycosylation | 1 | 2023 | 139 | 0.190 |
Why?
|
| Receptor, PAR-1 | 2 | 2014 | 5 | 0.190 |
Why?
|
| Research Design | 1 | 2026 | 590 | 0.190 |
Why?
|
| Stress, Mechanical | 1 | 2023 | 117 | 0.190 |
Why?
|
| Fluorescent Dyes | 3 | 2019 | 202 | 0.190 |
Why?
|
| Fluorocarbons | 1 | 2023 | 52 | 0.190 |
Why?
|
| Enterocytozoon | 1 | 2022 | 2 | 0.190 |
Why?
|
| Skin Aging | 1 | 2022 | 11 | 0.190 |
Why?
|
| Quantum Dots | 1 | 2023 | 31 | 0.190 |
Why?
|
| Trehalose | 1 | 2022 | 12 | 0.190 |
Why?
|
| Palaemonidae | 1 | 2022 | 5 | 0.190 |
Why?
|
| Stress, Physiological | 1 | 2025 | 210 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 6 | 2024 | 868 | 0.190 |
Why?
|
| Adipokines | 1 | 2023 | 37 | 0.190 |
Why?
|
| Lung Injury | 1 | 2023 | 36 | 0.190 |
Why?
|
| Models, Statistical | 1 | 2024 | 309 | 0.190 |
Why?
|
| Particle Size | 1 | 2024 | 431 | 0.190 |
Why?
|
| Obesity, Abdominal | 1 | 2022 | 10 | 0.190 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 364 | 0.190 |
Why?
|
| Machine Learning | 1 | 2024 | 195 | 0.190 |
Why?
|
| Pyroptosis | 1 | 2023 | 38 | 0.190 |
Why?
|
| Blood Glucose | 1 | 2025 | 502 | 0.190 |
Why?
|
| Tretinoin | 1 | 2022 | 49 | 0.180 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 92 | 0.180 |
Why?
|
| Intra-Abdominal Fat | 1 | 2022 | 37 | 0.180 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 181 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 408 | 0.180 |
Why?
|
| Dysferlin | 1 | 2022 | 15 | 0.180 |
Why?
|
| Interoception | 1 | 2022 | 2 | 0.180 |
Why?
|
| Transducers | 1 | 2022 | 23 | 0.180 |
Why?
|
| DNA, Catalytic | 2 | 2018 | 4 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2019 | 419 | 0.180 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 294 | 0.180 |
Why?
|
| Folic Acid | 1 | 2022 | 42 | 0.180 |
Why?
|
| Base Sequence | 2 | 2023 | 1331 | 0.180 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2023 | 146 | 0.180 |
Why?
|
| Intestines | 1 | 2023 | 182 | 0.180 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2019 | 94 | 0.170 |
Why?
|
| Time Factors | 2 | 2026 | 3774 | 0.170 |
Why?
|
| Phthalazines | 1 | 2021 | 3 | 0.170 |
Why?
|
| Trefoil Factor-3 | 2 | 2019 | 4 | 0.170 |
Why?
|
| Feces | 1 | 2022 | 118 | 0.170 |
Why?
|
| Aptamers, Nucleotide | 1 | 2021 | 27 | 0.170 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 40 | 0.170 |
Why?
|
| Kidney Failure, Chronic | 1 | 2023 | 197 | 0.170 |
Why?
|
| Mutation | 4 | 2025 | 2666 | 0.170 |
Why?
|
| Light Signal Transduction | 2 | 2011 | 6 | 0.170 |
Why?
|
| Pulse | 1 | 2021 | 16 | 0.170 |
Why?
|
| Animal Welfare | 1 | 2021 | 13 | 0.170 |
Why?
|
| Dendrites | 4 | 2018 | 60 | 0.170 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2018 | 36 | 0.170 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1225 | 0.170 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2021 | 3 | 0.170 |
Why?
|
| Amino Acid Sequence | 6 | 2014 | 1588 | 0.170 |
Why?
|
| Organ Transplantation | 1 | 2021 | 46 | 0.170 |
Why?
|
| Attitude | 1 | 2021 | 100 | 0.170 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 1979 | 0.170 |
Why?
|
| SEER Program | 1 | 2021 | 75 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2025 | 346 | 0.170 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2021 | 22 | 0.170 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 83 | 0.170 |
Why?
|
| Piperazines | 1 | 2021 | 86 | 0.170 |
Why?
|
| Simplexvirus | 1 | 2021 | 26 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 319 | 0.160 |
Why?
|
| Contrast Media | 1 | 2023 | 432 | 0.160 |
Why?
|
| Burkholderia pseudomallei | 1 | 2020 | 4 | 0.160 |
Why?
|
| Exosomes | 1 | 2021 | 54 | 0.160 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 296 | 0.160 |
Why?
|
| Rats | 6 | 2023 | 1996 | 0.160 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 58 | 0.160 |
Why?
|
| Prosthesis Design | 1 | 2021 | 222 | 0.160 |
Why?
|
| Survival Analysis | 5 | 2026 | 579 | 0.160 |
Why?
|
| Microglia | 2 | 2021 | 250 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 161 | 0.160 |
Why?
|
| Sciatic Nerve | 1 | 2020 | 31 | 0.160 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 160 | 0.160 |
Why?
|
| Wound Healing | 3 | 2023 | 193 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 281 | 0.160 |
Why?
|
| Cytokines | 1 | 2024 | 956 | 0.160 |
Why?
|
| Plant Extracts | 1 | 2022 | 130 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2020 | 35 | 0.160 |
Why?
|
| TRPV Cation Channels | 1 | 2020 | 21 | 0.160 |
Why?
|
| History, 21st Century | 1 | 2021 | 180 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2021 | 887 | 0.160 |
Why?
|
| Isopentenyladenosine | 1 | 2020 | 1 | 0.160 |
Why?
|
| Larva | 4 | 2018 | 158 | 0.160 |
Why?
|
| Chromosomes, Plant | 1 | 2020 | 4 | 0.160 |
Why?
|
| Plant Shoots | 1 | 2020 | 3 | 0.160 |
Why?
|
| Genes, Plant | 1 | 2020 | 21 | 0.160 |
Why?
|
| Parkinson Disease | 1 | 2022 | 135 | 0.160 |
Why?
|
| Integrons | 1 | 2020 | 3 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 94 | 0.160 |
Why?
|
| Osmotic Pressure | 1 | 2020 | 17 | 0.160 |
Why?
|
| History, 20th Century | 1 | 2021 | 233 | 0.160 |
Why?
|
| Lipase | 1 | 2020 | 52 | 0.160 |
Why?
|
| Disulfides | 1 | 2020 | 67 | 0.160 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 19 | 0.160 |
Why?
|
| Graft Rejection | 1 | 2021 | 303 | 0.150 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 154 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2022 | 300 | 0.150 |
Why?
|
| Indoleacetic Acids | 1 | 2020 | 31 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2020 | 27 | 0.150 |
Why?
|
| Electromagnetic Radiation | 1 | 2019 | 1 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2019 | 19 | 0.150 |
Why?
|
| DNA Repair | 2 | 2023 | 263 | 0.150 |
Why?
|
| Catheter Ablation | 1 | 2022 | 160 | 0.150 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 37 | 0.150 |
Why?
|
| Recurrence | 1 | 2021 | 662 | 0.150 |
Why?
|
| Kinetics | 2 | 2020 | 757 | 0.150 |
Why?
|
| Borrelia burgdorferi | 1 | 2021 | 93 | 0.150 |
Why?
|
| Neurofibromin 2 | 1 | 2019 | 4 | 0.150 |
Why?
|
| Cell Survival | 3 | 2017 | 588 | 0.150 |
Why?
|
| DNA Probes | 1 | 2019 | 33 | 0.150 |
Why?
|
| Osteosarcoma | 1 | 2019 | 48 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 151 | 0.150 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2019 | 36 | 0.150 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 25 | 0.150 |
Why?
|
| Proportional Hazards Models | 5 | 2023 | 745 | 0.150 |
Why?
|
| Protein Multimerization | 1 | 2020 | 181 | 0.150 |
Why?
|
| Integrin beta1 | 1 | 2019 | 32 | 0.150 |
Why?
|
| Risk Factors | 5 | 2021 | 5462 | 0.150 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 56 | 0.150 |
Why?
|
| Thermodynamics | 1 | 2020 | 196 | 0.150 |
Why?
|
| Femoral Neck Fractures | 1 | 2019 | 12 | 0.150 |
Why?
|
| Acidic Glycosphingolipids | 1 | 2019 | 1 | 0.150 |
Why?
|
| Exonucleases | 1 | 2019 | 6 | 0.150 |
Why?
|
| Autistic Disorder | 1 | 2022 | 159 | 0.150 |
Why?
|
| Trefoil Factor-2 | 3 | 2014 | 9 | 0.150 |
Why?
|
| Mice, Knockout | 5 | 2024 | 2162 | 0.150 |
Why?
|
| Deoxyguanosine | 1 | 2019 | 19 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 677 | 0.150 |
Why?
|
| Oxidation-Reduction | 3 | 2026 | 328 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2020 | 81 | 0.150 |
Why?
|
| Emotions | 1 | 2021 | 234 | 0.150 |
Why?
|
| Chloramphenicol | 1 | 2018 | 6 | 0.140 |
Why?
|
| Catalytic Domain | 1 | 2020 | 198 | 0.140 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2018 | 20 | 0.140 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 206 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 95 | 0.140 |
Why?
|
| Limit of Detection | 4 | 2019 | 49 | 0.140 |
Why?
|
| NF-kappa B | 2 | 2023 | 435 | 0.140 |
Why?
|
| Genomics | 1 | 2022 | 386 | 0.140 |
Why?
|
| Osteoporotic Fractures | 1 | 2019 | 36 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 300 | 0.140 |
Why?
|
| Calcium Signaling | 1 | 2020 | 164 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 354 | 0.140 |
Why?
|
| Carcinogenesis | 2 | 2017 | 135 | 0.140 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 468 | 0.140 |
Why?
|
| Complex Mixtures | 1 | 2018 | 7 | 0.140 |
Why?
|
| Crystallography, X-Ray | 1 | 2020 | 413 | 0.140 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 181 | 0.140 |
Why?
|
| RNA, Viral | 1 | 2020 | 266 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 181 | 0.140 |
Why?
|
| Smartphone | 1 | 2019 | 75 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 308 | 0.140 |
Why?
|
| Ethanol | 1 | 2022 | 333 | 0.140 |
Why?
|
| Testis | 1 | 2019 | 160 | 0.140 |
Why?
|
| Cell Division | 1 | 2020 | 450 | 0.140 |
Why?
|
| Protein Binding | 2 | 2020 | 1632 | 0.140 |
Why?
|
| Bone Density | 1 | 2019 | 142 | 0.140 |
Why?
|
| Chemokine CXCL5 | 1 | 2018 | 9 | 0.140 |
Why?
|
| Arthropod Venoms | 1 | 2018 | 1 | 0.140 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 11 | 0.140 |
Why?
|
| Arthropod Proteins | 1 | 2018 | 8 | 0.140 |
Why?
|
| Adolescent | 5 | 2021 | 6333 | 0.140 |
Why?
|
| Arthropods | 1 | 2018 | 8 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 216 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2024 | 84 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 146 | 0.130 |
Why?
|
| Skin | 3 | 2022 | 428 | 0.130 |
Why?
|
| Allergens | 1 | 2018 | 54 | 0.130 |
Why?
|
| Immunity, Innate | 2 | 2014 | 828 | 0.130 |
Why?
|
| Antibodies | 1 | 2018 | 187 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 156 | 0.130 |
Why?
|
| Nasopharynx | 1 | 2017 | 21 | 0.130 |
Why?
|
| Regeneration | 1 | 2019 | 126 | 0.130 |
Why?
|
| Obesity | 1 | 2026 | 1276 | 0.130 |
Why?
|
| NEDD8 Protein | 1 | 2017 | 1 | 0.130 |
Why?
|
| Cyclopentanes | 1 | 2017 | 9 | 0.130 |
Why?
|
| Lithium Compounds | 1 | 2017 | 10 | 0.130 |
Why?
|
| Communication | 1 | 2022 | 600 | 0.130 |
Why?
|
| Microtubules | 1 | 2018 | 210 | 0.130 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2017 | 8 | 0.130 |
Why?
|
| Candidiasis | 1 | 2017 | 49 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2015 | 924 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2021 | 1021 | 0.130 |
Why?
|
| Binding Sites | 1 | 2020 | 917 | 0.130 |
Why?
|
| Proline | 1 | 2017 | 46 | 0.130 |
Why?
|
| Cell Membrane | 1 | 2019 | 506 | 0.130 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2017 | 17 | 0.130 |
Why?
|
| Oviposition | 1 | 2016 | 4 | 0.130 |
Why?
|
| Chemoreceptor Cells | 1 | 2016 | 5 | 0.130 |
Why?
|
| Biocatalysis | 1 | 2017 | 50 | 0.130 |
Why?
|
| Hep G2 Cells | 3 | 2021 | 28 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 404 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 149 | 0.120 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 274 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2024 | 822 | 0.120 |
Why?
|
| S Phase | 1 | 2017 | 79 | 0.120 |
Why?
|
| Waiting Lists | 1 | 2017 | 55 | 0.120 |
Why?
|
| Methyltransferases | 1 | 2017 | 67 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2017 | 144 | 0.120 |
Why?
|
| Deception | 1 | 2016 | 7 | 0.120 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2016 | 9 | 0.120 |
Why?
|
| Tachykinins | 1 | 2015 | 8 | 0.120 |
Why?
|
| Lymphatic Metastasis | 3 | 2025 | 93 | 0.120 |
Why?
|
| Optogenetics | 1 | 2016 | 31 | 0.120 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 18 | 0.120 |
Why?
|
| Endemic Diseases | 1 | 2015 | 23 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 1 | 2015 | 19 | 0.120 |
Why?
|
| Iodine Radioisotopes | 1 | 2015 | 61 | 0.110 |
Why?
|
| Amygdala | 1 | 2016 | 85 | 0.110 |
Why?
|
| Diet | 1 | 2019 | 536 | 0.110 |
Why?
|
| Hepatitis B | 1 | 2015 | 28 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2017 | 133 | 0.110 |
Why?
|
| Neural Inhibition | 1 | 2015 | 30 | 0.110 |
Why?
|
| Antipyrine | 1 | 2015 | 1 | 0.110 |
Why?
|
| Synapses | 2 | 2021 | 195 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 734 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 128 | 0.110 |
Why?
|
| Reward | 1 | 2015 | 89 | 0.110 |
Why?
|
| DNA Replication | 1 | 2017 | 249 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2015 | 63 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2020 | 714 | 0.110 |
Why?
|
| Histone Demethylases | 1 | 2015 | 28 | 0.110 |
Why?
|
| Hedgehog Proteins | 1 | 2015 | 116 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2015 | 104 | 0.110 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 6 | 0.110 |
Why?
|
| Arachidonic Acid | 1 | 2014 | 38 | 0.110 |
Why?
|
| Comamonas | 1 | 2014 | 2 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2015 | 240 | 0.100 |
Why?
|
| Afferent Pathways | 1 | 2014 | 16 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 870 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2022 | 624 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1232 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 42 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 115 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 46 | 0.100 |
Why?
|
| Attention | 1 | 2015 | 154 | 0.100 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 38 | 0.100 |
Why?
|
| Cyclobutanes | 2 | 2026 | 10 | 0.100 |
Why?
|
| Cognition | 3 | 2023 | 510 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 269 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2021 | 1334 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2024 | 1115 | 0.100 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2014 | 42 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2013 | 30 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 363 | 0.100 |
Why?
|
| Equipment Design | 2 | 2025 | 371 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2015 | 224 | 0.100 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 90 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 512 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2014 | 324 | 0.100 |
Why?
|
| Endocytosis | 1 | 2014 | 152 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2025 | 2633 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2014 | 209 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 344 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1008 | 0.100 |
Why?
|
| Keratinocytes | 2 | 2023 | 72 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2019 | 287 | 0.090 |
Why?
|
| Touch | 1 | 2012 | 27 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 131 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2011 | 108 | 0.090 |
Why?
|
| Kidney | 2 | 2025 | 455 | 0.090 |
Why?
|
| Lysine | 2 | 2015 | 93 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2012 | 169 | 0.090 |
Why?
|
| Decision Making | 1 | 2016 | 422 | 0.090 |
Why?
|
| Biological Products | 1 | 2013 | 93 | 0.090 |
Why?
|
| Cloning, Molecular | 2 | 2009 | 385 | 0.090 |
Why?
|
| HeLa Cells | 3 | 2019 | 541 | 0.090 |
Why?
|
| Photochemical Processes | 2 | 2025 | 18 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 428 | 0.090 |
Why?
|
| Receptors, Thrombin | 1 | 2011 | 1 | 0.090 |
Why?
|
| Survival Rate | 2 | 2025 | 847 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2014 | 790 | 0.080 |
Why?
|
| Animal Structures | 1 | 2010 | 6 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 2495 | 0.080 |
Why?
|
| Dermis | 1 | 2010 | 22 | 0.080 |
Why?
|
| Avoidance Learning | 1 | 2010 | 27 | 0.080 |
Why?
|
| Gene Expression | 2 | 2019 | 854 | 0.080 |
Why?
|
| Methionine | 2 | 2023 | 57 | 0.080 |
Why?
|
| Indoles | 2 | 2024 | 112 | 0.080 |
Why?
|
| DNA Primers | 2 | 2022 | 301 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2014 | 352 | 0.080 |
Why?
|
| Uncoupling Protein 1 | 2 | 2026 | 51 | 0.080 |
Why?
|
| Lampreys | 1 | 2009 | 6 | 0.080 |
Why?
|
| Sepsis | 1 | 2013 | 302 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2025 | 857 | 0.080 |
Why?
|
| Radiotherapy Dosage | 2 | 2021 | 88 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2016 | 548 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2025 | 589 | 0.080 |
Why?
|
| Liver | 2 | 2024 | 871 | 0.070 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2023 | 45 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 426 | 0.070 |
Why?
|
| Electrodes | 2 | 2019 | 39 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2019 | 100 | 0.070 |
Why?
|
| Sexual Behavior, Animal | 1 | 2009 | 88 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 109 | 0.070 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2019 | 47 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 431 | 0.070 |
Why?
|
| Oxygen | 2 | 2023 | 321 | 0.070 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 19 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 203 | 0.070 |
Why?
|
| Hot Temperature | 2 | 2020 | 147 | 0.070 |
Why?
|
| Nausea | 2 | 2018 | 111 | 0.060 |
Why?
|
| Neutropenia | 2 | 2018 | 68 | 0.060 |
Why?
|
| Age Factors | 2 | 2024 | 1592 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 376 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2012 | 300 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2019 | 611 | 0.060 |
Why?
|
| Megakaryocytes | 1 | 2026 | 19 | 0.060 |
Why?
|
| Calcium | 2 | 2020 | 584 | 0.060 |
Why?
|
| Chondrosarcoma | 1 | 2026 | 7 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 672 | 0.060 |
Why?
|
| Clone Cells | 1 | 2026 | 111 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2025 | 35 | 0.060 |
Why?
|
| Disinfection | 1 | 2026 | 23 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2025 | 30 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2020 | 312 | 0.060 |
Why?
|
| Metabolomics | 1 | 2026 | 63 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2025 | 10 | 0.060 |
Why?
|
| Transcription Factor CHOP | 1 | 2025 | 8 | 0.060 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2025 | 10 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2025 | 1387 | 0.060 |
Why?
|
| Adipose Tissue, White | 1 | 2026 | 93 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2026 | 86 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2017 | 141 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2026 | 110 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2026 | 128 | 0.060 |
Why?
|
| Ubiquinone | 1 | 2025 | 22 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2026 | 156 | 0.060 |
Why?
|
| CA-125 Antigen | 1 | 2024 | 5 | 0.060 |
Why?
|
| Datasets as Topic | 1 | 2025 | 29 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2017 | 371 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2025 | 208 | 0.060 |
Why?
|
| Photosynthesis | 1 | 2024 | 10 | 0.050 |
Why?
|
| Genomic Structural Variation | 1 | 2024 | 5 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2016 | 232 | 0.050 |
Why?
|
| Pedigree | 1 | 2025 | 193 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2026 | 128 | 0.050 |
Why?
|
| Bronchi | 2 | 2015 | 85 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2025 | 78 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2026 | 125 | 0.050 |
Why?
|
| Polyethyleneimine | 1 | 2024 | 10 | 0.050 |
Why?
|
| Receptor, PAR-2 | 1 | 2024 | 4 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 573 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2024 | 17 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2026 | 282 | 0.050 |
Why?
|
| Lung | 2 | 2023 | 969 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2024 | 61 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 2024 | 27 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2024 | 24 | 0.050 |
Why?
|
| Carbon Tetrachloride | 1 | 2024 | 11 | 0.050 |
Why?
|
| Discriminant Analysis | 1 | 2024 | 20 | 0.050 |
Why?
|
| Connectin | 1 | 2024 | 14 | 0.050 |
Why?
|
| Malondialdehyde | 1 | 2024 | 16 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2026 | 300 | 0.050 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2024 | 28 | 0.050 |
Why?
|
| Fabaceae | 1 | 2024 | 10 | 0.050 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2024 | 61 | 0.050 |
Why?
|
| Adsorption | 1 | 2024 | 87 | 0.050 |
Why?
|
| Glutathione Peroxidase | 1 | 2024 | 28 | 0.050 |
Why?
|
| Cadherins | 1 | 2024 | 90 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2024 | 65 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2024 | 51 | 0.050 |
Why?
|
| Membranes, Artificial | 1 | 2024 | 46 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2778 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 240 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 204 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2025 | 231 | 0.050 |
Why?
|
| RNA Interference | 2 | 2019 | 644 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2025 | 301 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 31 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 102 | 0.050 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2023 | 4 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2023 | 11 | 0.050 |
Why?
|
| Lead | 1 | 2023 | 46 | 0.050 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 81 | 0.050 |
Why?
|
| Neuroimaging | 1 | 2025 | 165 | 0.050 |
Why?
|
| Adipocytes | 1 | 2026 | 274 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 17 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2025 | 744 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2015 | 617 | 0.050 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2023 | 1 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 6 | 0.050 |
Why?
|
| Resistin | 1 | 2023 | 7 | 0.050 |
Why?
|
| Actins | 1 | 2024 | 264 | 0.050 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2022 | 9 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2026 | 400 | 0.050 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2022 | 3 | 0.050 |
Why?
|
| Adiponectin | 1 | 2023 | 37 | 0.050 |
Why?
|
| Self Report | 1 | 2025 | 391 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2022 | 20 | 0.050 |
Why?
|
| Fresh Water | 1 | 2022 | 13 | 0.050 |
Why?
|
| Carbon | 1 | 2023 | 52 | 0.050 |
Why?
|
| Cancer Survivors | 1 | 2024 | 130 | 0.050 |
Why?
|
| Leptin | 1 | 2023 | 88 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2024 | 395 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2023 | 146 | 0.050 |
Why?
|
| Necrosis | 1 | 2022 | 148 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2023 | 196 | 0.050 |
Why?
|
| Vena Cava, Superior | 1 | 2022 | 9 | 0.040 |
Why?
|
| Ventral Striatum | 1 | 2021 | 2 | 0.040 |
Why?
|
| Guilt | 1 | 2021 | 7 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2023 | 191 | 0.040 |
Why?
|
| Granzymes | 1 | 2021 | 22 | 0.040 |
Why?
|
| Ferrous Compounds | 1 | 2021 | 11 | 0.040 |
Why?
|
| Zebrafish | 1 | 2025 | 374 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1710 | 0.040 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 39 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 115 | 0.040 |
Why?
|
| Breast | 1 | 2023 | 192 | 0.040 |
Why?
|
| Glutathione | 1 | 2021 | 55 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1285 | 0.040 |
Why?
|
| Anxiety | 1 | 2024 | 427 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 513 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2023 | 491 | 0.040 |
Why?
|
| Polymers | 1 | 2024 | 331 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 422 | 0.040 |
Why?
|
| Capsaicin | 1 | 2020 | 19 | 0.040 |
Why?
|
| Acyltransferases | 1 | 2020 | 33 | 0.040 |
Why?
|
| Wings, Animal | 1 | 2020 | 28 | 0.040 |
Why?
|
| Acrylic Resins | 1 | 2020 | 21 | 0.040 |
Why?
|
| Lipid Droplets | 1 | 2020 | 35 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 139 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2020 | 91 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 72 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 17 | 0.040 |
Why?
|
| Microscopic Polyangiitis | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2020 | 65 | 0.040 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2019 | 13 | 0.040 |
Why?
|
| Radio Waves | 1 | 2019 | 19 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 153 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 897 | 0.040 |
Why?
|
| Nutritive Value | 1 | 2019 | 37 | 0.040 |
Why?
|
| Carbocyanines | 1 | 2019 | 31 | 0.040 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2019 | 3 | 0.040 |
Why?
|
| Aeromonas hydrophila | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cerebrosides | 1 | 2019 | 4 | 0.040 |
Why?
|
| Growth Cones | 1 | 2019 | 14 | 0.040 |
Why?
|
| Meperidine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2019 | 128 | 0.040 |
Why?
|
| Gangliosides | 1 | 2019 | 19 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2019 | 21 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 23 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2019 | 45 | 0.040 |
Why?
|
| Sphingosine | 1 | 2019 | 20 | 0.040 |
Why?
|
| Hazard Analysis and Critical Control Points | 1 | 2018 | 1 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 289 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 982 | 0.040 |
Why?
|
| Ceramides | 1 | 2019 | 24 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 233 | 0.040 |
Why?
|
| Reproduction | 1 | 2019 | 99 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 2018 | 12 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2018 | 27 | 0.040 |
Why?
|
| Digoxigenin | 1 | 2018 | 1 | 0.040 |
Why?
|
| Ions | 1 | 2018 | 54 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2020 | 148 | 0.040 |
Why?
|
| Membrane Microdomains | 1 | 2019 | 51 | 0.040 |
Why?
|
| Metals | 1 | 2018 | 65 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 211 | 0.040 |
Why?
|
| Acetylation | 1 | 2018 | 121 | 0.030 |
Why?
|
| Comorbidity | 1 | 2022 | 1120 | 0.030 |
Why?
|
| Bridged-Ring Compounds | 1 | 2018 | 8 | 0.030 |
Why?
|
| Taxoids | 1 | 2018 | 25 | 0.030 |
Why?
|
| Anorexia | 1 | 2018 | 4 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2018 | 48 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2018 | 120 | 0.030 |
Why?
|
| Hearing Disorders | 1 | 2018 | 10 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 405 | 0.030 |
Why?
|
| Chromatin | 1 | 2023 | 643 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 663 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 92 | 0.030 |
Why?
|
| Zinc | 1 | 2018 | 95 | 0.030 |
Why?
|
| Depression | 1 | 2024 | 908 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 2111 | 0.030 |
Why?
|
| Lithium Carbonate | 1 | 2017 | 13 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 398 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2017 | 32 | 0.030 |
Why?
|
| Candida | 1 | 2017 | 37 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2017 | 66 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 236 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 478 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 129 | 0.030 |
Why?
|
| Aftercare | 1 | 2017 | 77 | 0.030 |
Why?
|
| Taste | 1 | 2016 | 41 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 292 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 192 | 0.030 |
Why?
|
| Games, Experimental | 1 | 2016 | 5 | 0.030 |
Why?
|
| Ytterbium | 1 | 2016 | 2 | 0.030 |
Why?
|
| Yttrium | 1 | 2016 | 7 | 0.030 |
Why?
|
| Energy Transfer | 1 | 2016 | 10 | 0.030 |
Why?
|
| Valine | 1 | 2016 | 32 | 0.030 |
Why?
|
| Polymethyl Methacrylate | 1 | 2016 | 15 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2016 | 40 | 0.030 |
Why?
|
| Locomotion | 1 | 2016 | 111 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2015 | 18 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2017 | 257 | 0.030 |
Why?
|
| Oxidants, Photochemical | 1 | 2015 | 2 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2015 | 22 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 80 | 0.030 |
Why?
|
| Hepatitis B Core Antigens | 1 | 2015 | 5 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 631 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2015 | 33 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 24 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 133 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 1402 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 294 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 2015 | 34 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 196 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2016 | 102 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 96 | 0.030 |
Why?
|
| Judgment | 1 | 2015 | 37 | 0.030 |
Why?
|
| Wnt-5a Protein | 1 | 2015 | 8 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2015 | 89 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 51 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 113 | 0.030 |
Why?
|
| Neurotoxins | 1 | 2015 | 21 | 0.030 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2015 | 20 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 67 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 134 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2015 | 83 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 147 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 169 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2015 | 136 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 931 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 74 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 455 | 0.030 |
Why?
|
| Topography, Medical | 1 | 2014 | 3 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 22 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2014 | 25 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 44 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 606 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 16 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2013 | 23 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 674 | 0.030 |
Why?
|
| tau Proteins | 1 | 2015 | 210 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 152 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 200 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 700 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2015 | 234 | 0.020 |
Why?
|
| Proteolysis | 1 | 2014 | 154 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 708 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 405 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 449 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 995 | 0.020 |
Why?
|
| Floxuridine | 1 | 2012 | 5 | 0.020 |
Why?
|
| Carboplatin | 1 | 2012 | 47 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 235 | 0.020 |
Why?
|
| Child | 1 | 2022 | 4623 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2012 | 42 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 235 | 0.020 |
Why?
|
| Darkness | 1 | 2011 | 20 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2011 | 21 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 900 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2011 | 24 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 53 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2011 | 144 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2010 | 28 | 0.020 |
Why?
|
| Neutrophils | 1 | 2013 | 395 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2010 | 31 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 58 | 0.020 |
Why?
|
| Uncoupling Protein 2 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Protons | 1 | 2009 | 67 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2009 | 5 | 0.020 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2009 | 7 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2009 | 26 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 213 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 94 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 391 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1632 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 1038 | 0.020 |
Why?
|
| United States | 1 | 2018 | 8149 | 0.010 |
Why?
|